Stock Price Decline Raises Questions for Alpha Tau Alpha Tau Medical saw its stock price drop by 2.7%, trading at $0.22 with a sharp decline in trading volume. Despite this, the company remains focused on clinical advancements, including FDA-approved trials for its Alpha DaRT technology, which could drive future growth.34